home / stock / prph / prph short
Short Information | ProPhase Labs Inc. (NASDAQ:PRPH)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 206,888 |
Total Actual Volume | 2,187,952 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 10,344 |
Average Short Percentage | 15.59% |
Is there a PRPH Short Squeeze or Breakout about to happen?
See the PRPH Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-22-2024 | $5.17 | $4.9 | $5.17 | $4.9 | 62,107 | 9,124 | 14.69% |
04-19-2024 | $5.31 | $5.26 | $5.31 | $5.05 | 99,267 | 17,590 | 17.72% |
04-18-2024 | $6.32 | $5.44 | $6.32 | $5.33 | 1,176,783 | 20,860 | 1.77% |
04-17-2024 | $7.47 | $6.27 | $7.47 | $6.051 | 83,037 | 6,798 | 8.19% |
04-16-2024 | $6.54 | $7.35 | $7.48 | $6.27 | 190,036 | 50,993 | 26.83% |
04-15-2024 | $6.63 | $6.155 | $6.77 | $6.115 | 48,030 | 8,615 | 17.94% |
04-12-2024 | $6.58 | $6.52 | $6.64 | $6.291 | 27,388 | 1,522 | 5.56% |
04-11-2024 | $6.6 | $6.4 | $6.6999 | $6.18 | 83,174 | 24,396 | 29.33% |
04-10-2024 | $6.04 | $6.13 | $6.22 | $6.005 | 19,140 | 2,820 | 14.73% |
04-09-2024 | $6.61 | $6.1 | $6.6417 | $6.06 | 26,633 | 2,409 | 9.05% |
04-08-2024 | $6.88 | $6.6 | $6.88 | $6.5 | 35,748 | 7,279 | 20.36% |
04-05-2024 | $6.67 | $6.8 | $6.9162 | $6.67 | 45,638 | 11,042 | 24.19% |
04-04-2024 | $6.64 | $6.58 | $6.75 | $6.5032 | 21,742 | 4,346 | 19.99% |
04-03-2024 | $6.8 | $6.62 | $6.88 | $6.42 | 37,479 | 9,097 | 24.27% |
04-02-2024 | $6.95 | $6.89 | $6.96 | $6.76 | 50,253 | 6,573 | 13.08% |
04-01-2024 | $6.59 | $6.85 | $6.93 | $6.54 | 33,474 | 5,967 | 17.83% |
03-28-2024 | $6.46 | $6.47 | $6.55 | $6.2273 | 16,102 | 1,806 | 11.22% |
03-27-2024 | $6.38 | $6.26 | $6.7099 | $6.2101 | 32,797 | 3,386 | 10.32% |
03-26-2024 | $6.62 | $6.29 | $6.7 | $6.155 | 49,364 | 7,415 | 15.02% |
03-25-2024 | $5.85 | $6.2 | $6.2 | $5.75 | 49,760 | 4,850 | 9.75% |
News, Short Squeeze, Breakout and More Instantly...
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company...
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its progress on the commercialization of its breakthrough BE-Smart test fo...
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion – set for rapid revenue and profit growth Completes full transition and right sized opera...